Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SJ1008030 (compound 8) TFA is a selective JAK2-degrading PROTAC that inhibits the growth of MHH-CALL-4 leukemia cells with an IC50 of 5.4 nM, indicating its potential use for leukemia research [1].
説明 | SJ1008030 (compound 8) TFA is a selective JAK2-degrading PROTAC that inhibits the growth of MHH-CALL-4 leukemia cells with an IC50 of 5.4 nM, indicating its potential use for leukemia research [1]. |
In vitro | SJ1008030 (compound 8) exhibited activity in CRLF2r cell line (MHH-CALL-4) with an IC50 of 5.4 nM after 72-hour treatment with TFA [1]. Dose-dependent degradation of JAK, GSPT1, and IKZF1 was observed in MHH-CALL-4 cells treated with SJ1008030 (0-4.3 μM; 72 hours) TFA [1]. Additionally, SJ1008030 (0-10 μM; 24h) TFA dose-dependently degraded JAK2 and GSPT1 proteins in xenografted bone marrow cells SJBALL021415, indicating inhibition of the JAK-STAT signaling pathway [1]. |
分子量 | 987.96 |
分子式 | C44H44F3N13O9S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SJ1008030 TFA Angiogenesis Chromatin/Epigenetic JAK/STAT signaling PROTAC Stem Cells PROTACs JAK Inhibitor inhibitor inhibit